Timber Hill’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-11,700
Closed -$365K 2198
2016
Q4
$365K Buy
11,700
+2,100
+22% +$68K ﹤0.01% 1798
2016
Q3
$386K Sell
9,600
-51,300
-84% -$1.93M ﹤0.01% 1588
2016
Q2
$2.02M Sell
60,900
-11,100
-15% -$380K 0.01% 902
2016
Q1
$2.12M Buy
72,000
+12,900
+22% +$356K 0.01% 897
2015
Q4
$1.56M Sell
59,100
-27,300
-32% -$709K 0.01% 1102
2015
Q3
$2.05M Sell
86,400
-59,400
-41% -$1.43M 0.01% 998
2015
Q2
$3.46M Buy
145,800
+76,800
+111% +$1.73M 0.02% 762
2015
Q1
$1.64M Sell
69,000
-72,600
-51% -$1.63M 0.01% 1142
2014
Q4
$3.01M Buy
141,600
+67,200
+90% +$1.35M 0.01% 794
2014
Q3
$1.27M Sell
74,400
-36,000
-33% -$568K 0.01% 1437
2014
Q2
$1.58M Sell
110,400
-49,200
-31% -$667K 0.01% 1349
2014
Q1
$1.97M Sell
159,600
-103,200
-39% -$1.19M 0.01% 1179
2013
Q4
$2.88M Sell
262,800
-42,000
-14% -$473K 0.01% 1113
2013
Q3
$3.54M Buy
304,800
+67,200
+28% +$786K 0.01% 1068
2013
Q2
$2.66M Buy
+237,600
New +$2.81M 0.01% 1223

Other funds holding EW

Timber Hill's EW Position: Q3 2017 in Review

Timber Hill sold out of Edwards Lifesciences (EW) in Q3 2017, closing a stake of 5,616 shares — an estimated $221K sold.

Timber Hill first reported a position in EW in Q4 2014 and held it in 8 quarters. The position peaked at $1.06M in Q3 2015. 740 funds tracked by Wall St. Rank hold EW as of Q3 2017.

  • Timber Hill reported no remaining Edwards Lifesciences position as of Q3 2017 after selling out during the quarter.
  • Timber Hill sold 5,616 Edwards Lifesciences shares in Q3 2017, an estimated $221K.
  • Timber Hill first reported a position in Edwards Lifesciences in Q4 2014 and held it in 8 quarters.
  • Timber Hill's Edwards Lifesciences position peaked at $1.06M in Q3 2015.
  • 740 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2017.

Based on Timber Hill's 13F filing for Q3 2017, filed 7 Nov 2017.